Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Hollywall Entertainment Inc. (HWAL) Dedicated to Extending Broadband, Fiber Services to Communications Tech ‘Deserts’

Hollywall Entertainment Inc. is a widely diversified technology and broadcasting company, with revenue streams derived from an extensive catalog of music, film, television, software and game library rights The company is dedicated to ensuring rural communities largely bereft of reliable communications technology embodied in broadband Internet are able to gain access to quality and affordable […]

Rebranding Efforts Aimed at Better Describing Triccar Inc.’s New Business Model, Identity Moving Forward: Correlate Infrastructure Partners Inc. (TCCR)

Triccar Inc. completed the acquisition of Correlate Inc. and Loyal Enterprises LLC (dba Solar Sight Design) in December last year, setting the wheels in motion for a rebrand In a recent news release, the company announced a majority of its shareholders had consented to a name change that will see Triccar Inc. rebrand as Correlate […]

Nowigence Inc.’s (NOWG) Pluaris App Provides Ideal Solution for One Billion Knowledge Workers Around the World

Globally, there are one billion knowledge workers whose jobs require them to combine action with a level of domain expertise Providing these workers with information, tools they need to succeed is key Nowigence’s Pluaris app works 24/7 to turn narrative-intensive information into scrollable intelligence Cultivating and supporting a new generation of knowledge workers is “one […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Technology Continues to Showcase Ability to Improve Effectiveness of Existing Drug Brands

Health and wellness drug product innovator Lexaria Bioscience has developed a patented technology — DehydraTECH (TM) — which enhances the bioavailability of fat-soluble drugs and molecules Lexaria continues to research DehydraTECH’s ability to improve the speed and bioavailability of cannabidiol (“CBD”) in treating high blood pressure and epileptic conditions The company continues its research demonstrating […]

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Inks Retail Partnership with BESTIES Vegan Paradise to Strengthen its Retail Footprint and Product Offering

The partnership will see the rebranding of XMarket brick-and-mortar stores in Venice, and Hillcrest, California, under the BESTIES brand PlantX is confident that its partnership with BESTIES will accelerate the already significant growth for PlantX In the first month of the rebrand, PlantX posted a 30% growth in sales revenue Over the past year, PlantX […]

Facebook’s Former Head of Advertising Joins NobleCon18 Lineup

Noble Capital Markets has announced that Rob Goldman will be a featured Metaverse panelist at NobleCon18, which feature presentations from 120 public companies on April 20 and 21 at The Guitar Hotel near Miami, FL. Joining Facebook (NASDAQ: FB) in 2012 reporting directly to CEO Mark Zuckerberg, Goldman was charged with growing and monetizing the […]

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Continues to Focus on the Continued Growth of its Top-Line Revenue and Bottom-Line Results in a Move to achieve its 3-Year Success Plan

RWB’s mission has always been to become the superior and most recognizable cannabis company in the United States It seeks to achieve this by focusing on the continued growth of top-line revenue and bottom-line results through brand expansion, mergers, and acquisitions So far, in 2022, the company has announced the acquisition of PharmaCo, which sees […]

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Reiterates Commitment to Operational Excellence, Advancing Berubicin Recognition

In a video message to shareholders, CEO John Climaco detailed the operational and clinical progress made by lead drug candidate Berubicin despite market volatility and share price fluctuations CNS is currently enrolling patients into a potentially pivotal global drug trial of Berubicin for recurrent glioblastoma multiforme Interim analysis of the trial is currently expected as […]

 

From Our Blog

Wrap Technologies Inc. (NASDAQ: WRAP) Positions Non-Lethal Innovation at the Center of Public Safety Reform

August 7, 2026

Across the United States, a quiet but consequential shift is underway in how communities approach public safety. Rather than treating equipment, training and accountability as separate priorities, agencies are increasingly seeking integrated systems that connect the tools officers carry with the training that prepares them and the data that documents every encounter. This full-stack approach […]

Rotate your device 90° to view site.